CIK 0001840706
- Accelerated filer
- Emerging growth company
SOPHiA GENETICS SA
Sign in to watch- Ticker
- SOPH
- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Other
- Phone
- +41 216941060
- Business address
- LA PIECE, CH-1180, ROLLE, Switzerland, 00000
- Open-market buys, last 90 days
- $278,388
- in 2 filings
- Open-market sales, last 90 days
- $1,758,713
- in 31 filings, $1.7M under 10b5-1 plans
Net −$1,480,325. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-02 | Camblong Jurgi Chief Executive Officer | Grant or award | +431,211 | 431,211 | ||
| 2026-04-02 | Camblong Jurgi Chief Executive Officer | Grant or award · Share Option (Right to Buy) | +628,743 | 628,743 | ||
| 2026-04-02 | Puylaert Kevin Chief Sales Officer | Grant or award | +56,468 | 56,468 | ||
| 2026-04-02 | Puylaert Kevin Chief Sales Officer | Grant or award · Share Option (Right to Buy) | +82,335 | 82,335 | ||
| 2026-04-02 | CARDOZA GEORGE Chief Financial Officer | Grant or award | +112,936 | 112,936 | ||
| 2026-04-02 | CARDOZA GEORGE Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +164,671 | 164,671 | ||
| 2026-04-02 | Valente Manuela Chief People Officer | Grant or award | +71,869 | 71,869 | ||
| 2026-04-02 | Valente Manuela Chief People Officer | Grant or award · Share Option (Right to Buy) | +104,790 | 104,790 | ||
| 2026-04-02 | Van Well Daan Chief Legal Officer | Grant or award | +97,536 | 97,536 | ||
| 2026-04-02 | Van Well Daan Chief Legal Officer | Grant or award · Share Option (Right to Buy) | +142,216 | 142,216 | ||
| 2026-03-31 | Puylaert Kevin Chief Sales Officer | Sale | −3 | $4.71 | $14 | 92,383 |
| 2026-03-19 | Van Well Daan Chief Legal Officer | Sale 10b5-1 | −684 | $4.79 | $3K | 261,238 |
| 2026-03-19 | Camblong Jurgi Chief Executive Officer | Sale 10b5-1 | −4,486 | $4.77 | $21K | 3,302,839 |
| 2026-03-19 | Menu Philippe Chief Medical Officer | Sale 10b5-1 | −608 | $4.79 | $3K | 173,616 |
| 2026-03-19 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −608 | $4.78 | $3K | 537,116 |
| 2026-03-19 | Valente Manuela Chief People Officer | Sale 10b5-1 | −380 | $4.79 | $2K | 152,379 |
| 2026-03-19 | Muken Ross President | Sale 10b5-1 | −1,183 | $4.79 | $6K | 271,910 |
| 2026-03-19 | Puylaert Kevin Chief Sales Officer | Sale | −33 | $4.76 | $157 | 92,386 |
| 2026-03-19 | CARDOZA GEORGE Chief Financial Officer | Sale 10b5-1 | −774 | $4.79 | $4K | 184,858 |
Page 11 of 11 · 219 trades